Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1989
06/20/1989US4840946 Benzazolythio-carbapenem antibiotics
06/20/1989US4840943 Androst-4-ene-3,17-diones and process for their preparation
06/20/1989US4840941 Administering dextran sulfate
06/20/1989US4840939 Inhibiting glucose transport
06/20/1989US4840938 Pharmaceutical compositions containing anthracycline glycosides
06/20/1989US4840936 Antiflammatory, analgesic agent to prevent arrhythmias
06/20/1989US4840896 Human fertility hormones rna encoding by vectors
06/20/1989US4840798 Astringent gel composition and method for use
06/20/1989US4840617 Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
06/20/1989CA1256248A1 Process for preparing 2-(1-piperazinyl) pyrimidines
06/20/1989CA1256119A1 Acetyldicarnitine
06/20/1989CA1256114A1 Polycyclic compounds, their preparation and formulations containing them
06/20/1989CA1256113A1 Process for preparing 4h-1,2,4-triazole derivatives
06/20/1989CA1256112A1 Imidazolyl, triazolyl, and tetrazolyl compounds
06/20/1989CA1256111A1 Benzodiioxinopyrrole derivatives
06/20/1989CA1256109A1 Process for the preparation of derivatives of 4, 5-dihydrooxazoles
06/20/1989CA1256108A1 Process for the preparation of 1-pyridyl-alkyl-4-aryl piperazines which are useful as antihypertensive compounds, their separation into the respective optical antipodes, and the steroisomeric compounds so obtained
06/20/1989CA1256107A1 Pyrimidine derivatives, preparation thereof and use thereof
06/20/1989CA1256105A1 Substituted 1,8-naphthyridinones, processes for their preparation and pharmaceutical compositions containing them
06/20/1989CA1256103A1 PROCESS FOR THE PREPARATION OF 2-BROMO-.alpha.- ERGOCRYPTINE
06/20/1989CA1256032A1 Methods and compositions for treating viral infection
06/20/1989CA1256031A1 Pharmaceutical compositions containing diltiazem and alfuzosin
06/20/1989CA1256029A1 Process for making a stable pharmaceutical preparation of prostaglandin e compounds, and/or 15r thereof
06/20/1989CA1256020A1 Preparation for prophylaxis and treatment of myiases of animals
06/15/1989WO1989005346A1 Stimulation of stem cell growth by the bryostatins
06/15/1989WO1989005304A1 Macrocyclic compounds
06/15/1989WO1989005302A1 Aminopropanol derivatives of 1,4:3,6-dianhydro-hexitol nitrates, processes for their preparation and their use as medicaments
06/15/1989WO1989005299A1 Novel benzimidazole derivatives
06/15/1989WO1989005297A1 Compounds
06/15/1989WO1989005295A1 Acyl derivatives of hydroxypyrimidines
06/15/1989WO1989005289A1 Novel amines and their use
06/15/1989WO1989005152A1 Liposome-encapsulated anti-viral composition and method
06/15/1989WO1989005149A1 Methyl cellulose pharmaceutical composition
06/15/1989WO1989005146A2 Method for treatment of dyslipidemia in humans
06/15/1989WO1989005145A1 Method of inhibiting the activity of leukocyte derived cytokines
06/15/1989WO1989005144A1 Use of a glycine b partial agonist for memory and learning enhancement or treatment of a cognitive disorder
06/15/1989WO1989005143A1 Method of treating skin disorders
06/15/1989WO1989005141A1 Anti-retroviral drug
06/15/1989WO1989005135A1 Preparation for dental treatment and method for production of the preparation
06/15/1989DE3840076A1 Injectable solution of the thioctic acid salt with trometamol and/or basic amino acids
06/15/1989DE3741414A1 Use of calcium antagonists for the treatment of inflammations and oedemas
06/14/1989EP0320455A1 Araliphatyl aminoalcane diphosphonic acids
06/14/1989EP0320438A1 17-Halomethylene estratrienes
06/14/1989EP0320437A2 17-Methylene and 17-ethylidene estratrienes having an oestrogenic activity
06/14/1989EP0320362A1 Use of 3-hydroxy-2-(4-methoxyphenyl)-5(2-methylamino-ethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives in the preparation of medicaments inhibiting the platelet aggregation factor
06/14/1989EP0320361A1 3-Hydroxy-2-(4-methoxyphenyl)-5(2-methylaminoethyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-one derivatives, their preparation and their use in therapy
06/14/1989EP0320271A2 Dimethylsulfoxide and analogues as anti-retroviral agents
06/14/1989EP0320164A2 Method for preparing hylan and novel hylan product
06/14/1989EP0320136A2 Imidazoquinoxaline compounds and their preparation and use
06/14/1989EP0320097A1 Controlled absorption diltiazem formulations
06/14/1989EP0320075A1 8,9-Annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
06/14/1989EP0320051A1 Controlled release combination of carbidopa/levodopa
06/14/1989EP0320032A1 Pyridizinamine derivatives
06/14/1989EP0320006A2 Uses of 1,4-dihydropyridines
06/14/1989EP0320002A1 Inhalant
06/14/1989EP0319991A1 Association of pyrimidine derivatives and antibacterial agents to induce and stimulate the hair growth and to reduce hair loss
06/14/1989EP0319988A1 External dermatological composition
06/14/1989EP0319986A2 Fibrinolytic agents
06/14/1989EP0319983A1 Association of pyrimidine derivatives and calcium antagonists to induce and stimulate the hair growth and to reduce hair loss
06/14/1989EP0319965A1 Pharmaceutical preparation for tinea pedis
06/14/1989EP0319964A1 Film-formation-type antifungal preparation
06/14/1989EP0319963A1 Preparations of vitamin E for external use
06/14/1989EP0319962A2 Piperidinyl methanol derivatives for the treatment of anxiety
06/14/1989EP0319947A2 Bis-S-alkylbenzene derivatives
06/14/1989EP0319903A2 Pyrimidone compound and pharmaceutically acceptable salts thereof
06/14/1989EP0319902A2 Transdermal Absorptive drug formulation
06/14/1989EP0319900A2 Furyl, phenylene and thienyl leukotriene B4 analogues
06/14/1989EP0319890A1 A process for the preparation of monosialoganglioside
06/14/1989EP0319856A2 Antibiotic composition containing cephalosporin
06/14/1989EP0319824A1 D-cycloserine and its prodrugs as cognitive enhancers
06/14/1989EP0319676A2 Chondroitin polysulfate compositions for the treatment of immunodeficiencies caused by retroviruses
06/14/1989EP0319645A1 Cationized polysaccharide derivatives with hypocholesterolemic activity
06/14/1989EP0319598A1 Stabilized aqueous preparation of folic acid
06/14/1989EP0319559A1 Novel heparin derivatives
06/14/1989EP0142561B1 Long-acting nifedipine preparation
06/14/1989CN1033380A Compounds
06/14/1989CN1033379A Acyl derivatives of hydroxy pyrimidines
06/14/1989CN1004469B Process for separating pb, as si from sodium tangstate solution
06/13/1989US4839389 Treatment of diseases caused by human or animal immunodeficiency; effective against infectious diseases; escherichia
06/13/1989US4839388 Prostacyclins and pharmaceuticals containing the same
06/13/1989US4839387 Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
06/13/1989US4839385 Hypotensive agents, cardiotonic agents, atherosclerosis antiulcer agents, diarrhea, psoriaisis;blocks calcium entry or releae
06/13/1989US4839384 Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
06/13/1989US4839382 Anticoccidial compositions
06/13/1989US4839380 Antihypoxic agents
06/13/1989US4839379 Aromatase inhibitors
06/13/1989US4839377 5-substituted 3-aminoalkyl indoles
06/13/1989US4839376 Pyrazoline derivatives for treating cerebrovascular diseases
06/13/1989US4839375 (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents
06/13/1989US4839371 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
06/13/1989US4839370 Novel derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dione
06/13/1989US4839368 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
06/13/1989US4839367 Antihypertensive amide compounds
06/13/1989US4839366 Methylthioquinolyl guanidine derivative, process of preparation thereof and pharmaceutical compositions therefrom
06/13/1989US4839364 9-Amino-3,4-dihydroacridines and related compounds useful for enhancing memory
06/13/1989US4839363 Ergolinyl heterocycles for the treatment of Parkinson's disease and dyskinetic symptoms
06/13/1989US4839362 Vasodilators
06/13/1989US4839358 Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions and use
06/13/1989US4839355 Tricyclic-pyridinylquinoline compounds, their preparation and use
06/13/1989US4839354 Acetic acid analgesics with antitussives, antihistamines, decongestants
1 ... 7475 7476 7477 7478 7479 7480 7481 7482 7483 7484 7485 7486 7487 7488 7489 7490 7491 7492 7493 7494 7495 ... 7860